Document is current
Any future updates will be listed below
-
Authors
Iwahana, Togo
Okada, Sho http://orcid.org/0000-0002-1957-2282
Kanda, Masato
Oshima, Motohiko
Iwama, Atsushi
Matsumiya, Goro
Kobayashi, Yoshio
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP15K09064, JP15K09064, JP15K09064, JP15K09064)
- License Information
-
More Information
Article History
Received: 1 July 2019
Accepted: 21 February 2020
First Online: 5 March 2020
Ethics approval and consent to participate
: This study was approved by the Ethics Committee of Chiba University and was conducted according to the principles set forth by the Declaration of Helsinki. All participants provided written, informed consent for their participation.
: Not Applicable.
: TI, SO, GM, and YK have received research grants from Japan Society for the Promotion of Science KAKENHI grant (no. JP15K09064). AI has received consultancy fee from ReproCell Inc. GM received grants from Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan), DAIICHI SANKYO COMPANY, LIMITED (Tokyo, Japan), Abbott Medical Japan Co., Ltd. (Tokyo, Japan), Terumo Corporation (Tokyo, Japan), Century Medical, Inc. (Tokyo, Japan), and NIPRO CORPORATION (Osaka, Japan). YK received grants from Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan), Pfizer Inc. (New York, USA), Medtronic Japan Co., Ltd. (Tokyo, Japan), WIN INTERNATIONAL CO.,LTD (Tokyo, Japan), DAIICHI SANKYO COMPANY, LIMITED (Tokyo, Japan), Amgen Astellas BioPharma K.K (Tokyo, Japan), Mebix, Inc. (Tokyo, Japan), Japan Cardiovascular Research Foundation (Osaka, Japan), and EPI Yamanashi Co.,LTD (Kofu, Yamanashi).
